BR9810739A - Composições de sertralina solubilizada - Google Patents

Composições de sertralina solubilizada

Info

Publication number
BR9810739A
BR9810739A BR9810739-9A BR9810739A BR9810739A BR 9810739 A BR9810739 A BR 9810739A BR 9810739 A BR9810739 A BR 9810739A BR 9810739 A BR9810739 A BR 9810739A
Authority
BR
Brazil
Prior art keywords
compositions
sertraline
solubilized
solubilized sertraline
solubility
Prior art date
Application number
BR9810739-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Dwayne Thomas Friensen
Scott Max Herbig
Ravi Mysore Shanker
James Blair West
Original Assignee
Pfizer Productsd Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9810739(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Productsd Inc filed Critical Pfizer Productsd Inc
Publication of BR9810739A publication Critical patent/BR9810739A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9810739-9A 1997-07-01 1998-06-15 Composições de sertralina solubilizada BR9810739A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions

Publications (1)

Publication Number Publication Date
BR9810739A true BR9810739A (pt) 2000-09-12

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810739-9A BR9810739A (pt) 1997-07-01 1998-06-15 Composições de sertralina solubilizada

Country Status (34)

Country Link
EP (1) EP0999829A1 (no)
JP (1) JP2000514100A (no)
KR (1) KR100366373B1 (no)
CN (1) CN1261794A (no)
AP (1) AP1192A (no)
AR (3) AR015917A1 (no)
AU (1) AU742535B2 (no)
BG (1) BG103918A (no)
BR (1) BR9810739A (no)
CA (1) CA2290974C (no)
CO (1) CO4940495A1 (no)
DZ (1) DZ2548A1 (no)
EA (1) EA002481B1 (no)
HN (1) HN1998000102A (no)
HR (1) HRP980377A2 (no)
HU (1) HUP0002236A3 (no)
ID (1) ID23429A (no)
IL (1) IL133076A (no)
IS (1) IS5260A (no)
MA (1) MA24587A1 (no)
NO (1) NO996520L (no)
OA (1) OA11243A (no)
PA (1) PA8454301A1 (no)
PE (1) PE97199A1 (no)
PL (1) PL337804A1 (no)
SK (1) SK181099A3 (no)
TN (1) TNSN98124A1 (no)
TR (1) TR199903297T2 (no)
TW (1) TW550087B (no)
UA (1) UA67741C2 (no)
UY (1) UY25071A1 (no)
WO (1) WO1999001120A1 (no)
YU (1) YU68299A (no)
ZA (1) ZA985708B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1712222A3 (en) 1999-12-23 2012-06-20 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
EP2117652B1 (en) * 2007-03-12 2013-09-25 DSM IP Assets B.V. Cosmetic compositions
US20120289517A1 (en) * 2009-12-29 2012-11-15 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
US20130035344A1 (en) * 2009-12-29 2013-02-07 Kowa Co., Ltd. Pharmaceutical composition for oral administration
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DE69004529T2 (de) * 1989-08-30 1994-02-24 Pfizer Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
EA199900962A1 (ru) 2000-08-28
YU68299A (sh) 2002-06-19
AR015917A1 (es) 2001-05-30
OA11243A (en) 2003-07-24
PE97199A1 (es) 1999-10-05
HUP0002236A2 (hu) 2003-08-28
SK181099A3 (en) 2000-07-11
TW550087B (en) 2003-09-01
CA2290974A1 (en) 1999-01-14
AP9801280A0 (en) 1998-06-30
AU7544898A (en) 1999-01-25
BG103918A (en) 2000-07-31
CA2290974C (en) 2004-04-27
CN1261794A (zh) 2000-08-02
TR199903297T2 (xx) 2000-07-21
CO4940495A1 (es) 2000-07-24
KR20010013365A (ko) 2001-02-26
AU742535B2 (en) 2002-01-03
NO996520D0 (no) 1999-12-28
IL133076A (en) 2003-12-10
DZ2548A1 (fr) 2003-02-08
HRP980377A2 (en) 1999-04-30
AP1192A (en) 2003-07-23
EP0999829A1 (en) 2000-05-17
KR100366373B1 (ko) 2003-01-14
UY25071A1 (es) 2000-12-29
PL337804A1 (en) 2000-09-11
ID23429A (id) 2000-04-20
IL133076A0 (en) 2001-03-19
HUP0002236A3 (en) 2003-12-29
UA67741C2 (uk) 2004-07-15
AR040279A2 (es) 2005-03-23
MA24587A1 (fr) 1998-12-31
WO1999001120A1 (en) 1999-01-14
PA8454301A1 (es) 2000-09-29
HN1998000102A (es) 1999-01-08
JP2000514100A (ja) 2000-10-24
NO996520L (no) 2000-02-29
IS5260A (is) 1999-11-19
TNSN98124A1 (fr) 2005-03-15
AR040280A2 (es) 2005-03-23
EA002481B1 (ru) 2002-06-27
ZA985708B (en) 2000-01-10

Similar Documents

Publication Publication Date Title
BR9808895A (pt) Partìcula de detergente
BR9709048A (pt) Sistema de informação
HUP9900152A2 (hu) Alkoholalapú mikrobaellenes kozmetikai készítmény és alkalmazása
MX9603101A (es) Composiciones topicas acuosas.
BR0208543A (pt) Ambiente comutado em pacotes
GB9717905D0 (en) Lipid-containing compositions and uses thereof
FI963078A0 (fi) Vesipitoisia puhdistuskoostumuksia, jotka sisältävät 2-alkyylialkanolia, vetyperoksidia, anionista ainetta ja nonionista alhaisen HLB:n omaava ainetta
BR9913156A (pt) Composição e processo para condicionamento, clareamento e realce do cabelo
BR9813815A (pt) " tablete detergente "
BR0110506A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
HUP9701611A2 (hu) Nagy elektrolittartalmú V/O emulzió, alkalmazása bőrkozmetikai készítményekben, különösen irritáció és/vagy érzékeny bőr kezelésére
BR9810739A (pt) Composições de sertralina solubilizada
BR0207654A (pt) Composição que compreende um creme ou loção base
BR9610930A (pt) Composição depilatória incluindo uma quantidade funcional de um agente tixoitrópico, e, uso da quantidade funcional de um agente tixotrópico.
PL328916A1 (en) Compositions containing inhibitors of hiv protease, such as vx 478 and water-soluble vitamin e compound such as vitamin e-tpgs
ATE196992T1 (de) Feste, nicht zerfliessbare formulierung von natrium valproat
BR9712993A (pt) Composições orais contendo gluconato estanoso.
ES2154018T3 (es) Soluciones inyectables por via parenteral que contienen piroxicam.
ES2126267T3 (es) Procedimiento para suavizar tejidos.
MA25305A1 (fr) Compositions de blanchiment.
DK1156829T3 (da) Stabil formulering indeholdende fumagillin
DE59908266D1 (de) Koffer-tresor-system
MD980129A (en) Antiherpetic remedy
ES2149736T1 (es) Composiciones farmaceuticas conteniendo derivados de tienopiridina estables y libres de antioxidantes.
HUP0101455A2 (hu) Stabil antibakteriális, aromás karbanilidszármazékot tartalmazó készítmény, és eljárás karbanilidszármazék stabilizálására

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.